FinTest TM IgG4 Screen 90 ELISA
- Regulatory Status
- RUO
- Incubation time
- 1 x 1h; 1 x 30 min; 1 x 1 h
- Kit size
- 12 x 8
- Specimen / Volumes
- 25µL serum, plasma
- Standard range
- 0.35 17.5 U/mL
- Substrate / isotope
- PNPP 405 nm
| instructions for use |
|---|
| instructions for use |
|---|
Enzyme immunoassay (microtiter strips) for the quantitative determination of IgG4 antibodies against 90 food allergens in human serum and plasma.
Lucretius once said that one man’s food may be another man’s poison. Individuals with allergies and other
types of food sensitivities react adversely to certain foods and food ingredients that others can consume with
no problems. Many different types of reactions are involved in these individual adverse reactions. Adverse
food reactions may include IgE and non-IgE-mediated primary immunological sensitivities, non
immunological intolerances (such as an enzyme deficiency or reactions to certain chemicals), as well as
secondary sensitivities.
Adverse immune reactions to foods which are not IgE mediated are often called food “intolerances.” The
absence of IgE does not make them any less real; instead, other immune mechanisms, such as IgG or IgG4
antibodies are involved. IgG or IgG4-mediated adverse reactions to food are characterized by less severe
reactions, are much more common (affecting approx. 45 % of the population) and have delayed onset (2 to
72 hours) after ingestion of an offending substance. Avoiding ingestion of such food (exclusion or rotation
diet) is the best treatment to decrease symptoms.
There are several evidences for the involvement of IgG or IgG4 in food „intolerances“ e.g.:
• Allergic reactions may occur independently of antigen-specific IgE
• Subsequent decrease of IgG when the offending food is removed from the diet
• Specific serum IgG has been reported in cases of celiac disease, dermatitis, or atopic eczema, as well as
in diseases with increased intestinal permeability, and inflammatory bowel disease (IBD)
This evidence leads to the recommendation that IgG or IgG4-specific testing should be considered in cases
where the patient shows unclear and chronic disorders and in cases where classical diagnostics show no
evidence.
Distributed by Tecan, IBL International GmbH.
For concrete data please consult the Instruction for Use in the download box on the top right side.
For concrete data please consult the Instruction for Use in the download box on the top right side.
Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.
And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms.
All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use.
All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.
Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.
At Tecan, we are driven to improve people’s lives and health.